التفاصيل البيبلوغرافية
| العنوان: |
Establishing guidelines for pharmacotherapy trials in bulimia nervosa and anorexia nervosa. |
| المؤلفون: |
Mitchell JE (AUTHOR), Tareen B (AUTHOR), Sheehan W (AUTHOR), Agras S (AUTHOR), Brewerton TD (AUTHOR), Crow S (AUTHOR), Devlin M (AUTHOR), Eckert E (AUTHOR), Halmi K (AUTHOR), Herzog D (AUTHOR), Marcus M (AUTHOR), Powers P (AUTHOR), Stunkard A (AUTHOR), Walsh BT (AUTHOR) |
| المصدر: |
International Journal of Eating Disorders. Jul2000, Vol. 28 Issue 1, p1-7. 7p. |
| مستخلص: |
OBJECTIVE: This paper addresses the lack of a standard protocol for pharmacotherapy trials for patients with bulimia nervosa (BN) and anorexia nervosa (AN). METHOD: Twenty-two surveys were sent to established researchers in the field of eating disorders to elicit their opinions regarding medication trials, including baseline laboratory tests, the optimal length/frequency of medication management sessions, and the information that should or should not be included in these sessions. RESULTS: Sixteen of 22 researchers completed and returned the survey. Their answers are the basis of the data presented. DISCUSSION: We propose a battery of screening laboratory tests for both conditions. We suggest 30-45-min initial medication management sessions in both AN and BN trials with 15-min follow-ups to be held weekly for AN subjects, and weekly for 2 weeks, then biweekly for 2 weeks, then monthly, for BN subjects. We also recommend that published trials should include explicit details of medication management. Copyright 2000 John Wiley & Sons, Inc. [ABSTRACT FROM AUTHOR] |
| URL: |
3250747 |
| قاعدة البيانات: |
Academic Search Index |